The US Food and Drug Administration’s anesthesiology and respiratory therapy devices advisory committee agreed that pulse oximeters with decreased accuracy on patients with dark skin is a problem that comes with clinical implications.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?